Insider Stock Trading History of Lynch Samuel Eugene


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Lynch Samuel Eugene since year 2005. The trader's CIK number is 1362148. At the time of this reporting, Lynch Samuel Eugene is the President and CEO of Biomimetic Therapeutics, Inc. . (stock ticker symbol BMTI). See this page for all insider trading activities at Biomimetic Therapeutics, Inc. .

Note that in the past Lynch Samuel Eugene also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Lynch Samuel Eugene since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-03-01 BMTI Biomimetic Therapeutics, Inc. Option Ex 221,000 2.78 613,275
2012-03-29 BMTI Biomimetic Therapeutics, Inc. Buy 30,638 2.38 72,887
2012-03-30 BMTI Biomimetic Therapeutics, Inc. Buy 39,362 2.43 95,649
2012-03-23 BMTI Biomimetic Therapeutics, Inc. Buy 13,150 2.35 30,902
2011-06-30 GRNB Greene County Bancshares Inc Buy 1,518 2.62 3,977
2011-05-18 BMTI Biomimetic Therapeutics, Inc. Buy 13,000 7.82 101,725
2011-04-12 GRNB Greene County Bancshares Inc Buy 192 2.79 535
2010-12-30 BMTI Biomimetic Therapeutics, Inc. Option Ex 26,250 3.63 95,287
2009-12-28 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.56 34,680
2009-12-29 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.29 33,870
2009-12-14 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 12.32 36,960
2009-12-15 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 12.03 36,090
2009-12-02 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 10.94 32,820
2009-12-03 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.24 33,720
2009-11-16 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.80 35,400
2009-11-17 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.64 34,920
2009-11-05 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.70 35,100
2009-11-04 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.63 34,890
2009-10-20 BMTI Biomimetic Therapeutics, Inc. Sale 4,500 14.22 63,967
2009-10-21 BMTI Biomimetic Therapeutics, Inc. Sale 4,500 13.85 62,325
2009-10-05 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.50 34,515
2009-10-06 BMTI Biomimetic Therapeutics, Inc. Sale 4,500 12.57 56,556
2009-09-23 BMTI Biomimetic Therapeutics, Inc. Sale 4,500 13.08 58,864
2009-09-24 BMTI Biomimetic Therapeutics, Inc. Sale 4,500 12.98 58,432
2009-09-09 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 12.01 36,018
2009-09-10 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.99 35,982
2009-08-25 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.72 35,151
2009-08-26 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 11.47 34,404
2009-08-13 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 10.79 32,376
2009-08-12 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 10.85 32,541
2009-07-30 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 10.09 30,272
2009-07-29 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 9.84 29,535
2009-07-16 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 9.88 29,625
2009-07-17 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 9.78 29,339
2009-07-01 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 9.36 28,095
2009-06-30 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 9.28 27,852
2009-06-16 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 9.00 27,000
2009-06-17 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 9.03 27,078
2009-06-03 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 9.04 27,135
2009-06-04 BMTI Biomimetic Therapeutics, Inc. Sale 3,000 9.07 27,204
2009-01-29 BMTI Biomimetic Therapeutics, Inc. Sale 50,000 9.63 481,400
2008-10-27 BMTI Biomimetic Therapeutics, Inc. Option Ex 77,250 3.55 274,237
2008-03-28 BMTI Biomimetic Therapeutics, Inc. Buy 5,400 8.93 48,227
2007-02-14 BMTI Biomimetic Therapeutics, Inc. Sale 236,239 17.15 4,051,498
2006-05-12 BMTI Biomimetic Therapeutics, Inc. Buy 12,500 8.00 100,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lynch Samuel Eugene (President and CEO of Biomimetic Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.